GNB1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, GNB1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated GNB1 data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GNB1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated GNB1 expression acts as an unfavorable survival marker, although some lineages such as PDAC and HNSC show a favorable association.

UCEC, CCRCC, and LUAD are the cancer types where GNB1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECDFSTertileIII,IV0.2891.000.00816view →
CCRCCOSTertileAll0.7590.941.01214view →
LUADOSTertileIII,IV0.5360.994.03010view →
LSCCDFSTertileIII,IV0.4691.000.0026view →
PDACOSQuartileIII,IV0.9770.390.0115view →
HNSCDFSMedianIII,IV0.8870.680.0092view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

GNB1–UCEC (DFS)

Kaplan–Meier survival curve for GNB1 mass-spec protein-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration